Bibliography

Export 26 results:

Filters: Keyword is *Transplantation Immunology [Clear All Filters]

2005

Vercelli CA, Hidalgo AM, Hyon SH, Argibay PF. Trypanosoma cruzi trans-sialidase inhibits human lymphocyte proliferation by nonapoptotic mechanisms: implications in pathogenesis and transplant immunology. Transplant Proc. 2005;37(10):4594-7.

2002

Buell JF, Trofe J, Hanaway MJ, Beebe TM, Gross TG, Alloway RR, et al. Immunosuppression and Merkel cell cancer. Transplant Proc. 2002;34(5):1780-1.

1998

Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl. 1998:147-58.

1996

Penn I. Cancers in cyclosporine-treated vs azathioprine-treated patients. Transplant Proc. 1996;28(2):876-8.

1994

Penn I. Posttransplant malignancies in pediatric organ transplant recipients. Transplant Proc. 1994;26(5):2763-5.

1990

Brunson ME, Balakrishnan K, Penn I. HLA and Kaposi's sarcoma in solid organ transplantation. Hum Immunol. 1990;29(1):56-63.

Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl. 1990:53-62.

1983

Friedlaender GE. Immune responses to osteochondral allografts. Current knowledge and future directions. Clin Orthop Relat Res. 1983;(174):58-68.

1980

Penn I. Some contributions of transplantation to our knowledge of cancer. Transplant Proc. 1980;12(4):676-80.

1976

Friedlaender GE, Strong DM, Sell KW. Studies on the antigenicity of bone. I. Freeze-dried and deep-frozen bone allografts in rabbits. J Bone Joint Surg Am. 1976;58(6):854-8.

1973

Starzl TE, Groth CG, Putnam CW, Corman J, Halgrimson CG, Penn I, et al. Cyclophosphamide for clinical renal and hepatic transplantation. Transplant Proc. 1973;5(1):511-6.

Penn I, Starzl TE. Immunosuppression and cancer. Transplant Proc. 1973;5(1):943-7.

1972

Andres GA, Ansell ID, Halgrimson CG, Hsu KC, Porter KA, Starzl TE, et al. Immunopathological studies of orthotopic human liver allografts. Lancet. 1972;1(7745):275-80.

Starzl TE, Putnam CW, Halgrimson CG, Groth CG, S., Bynon J. J, Penn I. Renal transplantation under cyclophosphamide. Transplant Proc. 1972;4(4):461-4.

1971

Starzl TE, Putnam CW, Halgrimson CG, Schroter GT, Martineau G, Launois B, et al. Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet. 1971;133(6):981-91.

Starzl TE, Penn I, Putnam CW, Groth CG, Halgrimson CG. Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev. 1971;7:112-45.

1970

Andres GA, Accinni L, Hsu KC, Penn I, Porter KA, Rendall JM, et al. Human renal transplants. 3. Immunopathologic studies. Lab Invest. 1970;22(6):588-604.

Starzl TE, Penn I, Halgrimson CG. Immunosuppression and malignant neoplasms. N Engl J Med. 1970;283(17):934.

Starzl TE, Porter KA, Andres G, Halgrimson CG, Hurwitz R, Giles G, et al. Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg. 1970;172(3):437-72.

Penn I, Starzl TE. Malignant lymphomas in transplantation patients: a review of the world experience. Int Z Klin Pharmakol Ther Toxikol. 1970;3(1):49-54.

Starzl TE, Putnam CW, Brettschneider L, Penn I. The prospect of organ transplantation in cancer surgery. Proc Natl Cancer Conf. 1970;6:45-55.

Pappas G, Schroter G, Brettschneider L, Penn I, Starzl TE. Pulmonary surgery in immunosuppressed patients. J Thorac Cardiovasc Surg. 1970;59(6):882-7.

1969

Starzi TE, Brettschneider L, Penn I, Giles G, Picache R, Putnam CW. Clinical liver transplantation. Transplant Rev. 1969;2:3-68.

Starzl TE, Groth CG, Brettschneider L, Smith GV, Penn I, Kashiwagi N. Perspectives in organ transplantation. Antibiot Chemother. 1969;15:349-83.

1968

Wilson RE, Hager EB, Hampers CL, Corson JM, Merrill JP, Murray JE. Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med. 1968;278(9):479-83.

Pages